Revive Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.009; its P/E ratio is -2.28; Revive Therapeutics is scheduled to report earnings on May 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	C$ -340.17K	C$ -65.21K	-
Gross Profit	-	-	C$ -340.17K	C$ -65.21K	-
EBIT	C$ -764.72K	C$ -383.14K	C$ -1.18M	C$ -1.94M	C$ -1.52M
EBITDA	C$ -764.64K	C$ -383.06K	C$ -1.18M	C$ -1.94M	C$ -1.52M
Net Income Common Stockholders	C$ -770.62K	C$ -390.62K	C$ -1.18M	C$ -1.94M	C$ -1.52M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 708.41K	C$ 1.59M	C$ 2.09M	C$ 2.66M	C$ 710.17K
Total Assets	C$ 12.88M	C$ 13.78M	C$ 14.25M	C$ 15.77M	C$ 13.85M
Total Debt	C$ 156.05K	C$ 188.91K	C$ 219.69K	C$ 248.75K	C$ 276.39K
Net Debt	C$ -552.37K	C$ -1.40M	C$ -1.87M	C$ -2.41M	C$ -433.78K
Total Liabilities	C$ 3.35M	C$ 3.52M	C$ 3.60M	C$ 3.92M	C$ 4.33M
Stockholders Equity	C$ 9.53M	C$ 10.26M	C$ 10.65M	C$ 11.85M	C$ 9.51M
Cash Flow	-
Free Cash Flow	C$ -883.42K	C$ -495.53K	C$ -568.09K	C$ -2.16M	-
Operating Cash Flow	C$ -883.42K	C$ -495.53K	C$ -568.09K	C$ -2.16M	C$ -876.31K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	C$ 4.10M	-

Currency in CAD

Revive Therapeutics Earnings and Revenue History

Income Statement >

Revive Therapeutics Debt to Assets

Balance Sheet >

Revive Therapeutics Cash Flow

Cash Flow >

Revive Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing